Literature DB >> 23845451

"Hidden" bone metastasis from thyroid carcinoma: a clinical note.

C Sioka1, M C Skarulis2, M K Tulloch-Reid3, J D Heiss4, J C Reynolds5.   

Abstract

The (131)I-iodide ((131)I) whole-body scan, for thyroid carcinoma is at times difficult to interpret. In a diagnostic whole body (131)I scan of a patient with follicular carcinoma, a posterior skull lesion was partially hidden by overlapping facial structures. On lateral head view, the abnormality was clearly evident. SPECT/CT and MRI showed the lesion originated in the occipital bone and had enlarged into the posterior fossa. The mass was surgically removed and the patient received (131)I therapy for residual tissue. The study demonstrates a pitfall in the reading of two dimensional radioiodine images which can be overcome by SPECT or lateral imaging.
Copyright © 2013 Elsevier España, S.L. and SEMNIM. All rights reserved.

Entities:  

Keywords:  (131)I-Iodide; Cáncer folicular de tiroides; Enfermedad metastásica; Follicular thyroid cancer; Metastatic disease; Radioiodine therapy; SPECT; Terapia con yodo radioactivo; Yodo radioactivo (131)I

Mesh:

Substances:

Year:  2013        PMID: 23845451      PMCID: PMC4294188          DOI: 10.1016/j.remn.2013.05.009

Source DB:  PubMed          Journal:  Rev Esp Med Nucl Imagen Mol        ISSN: 2253-654X            Impact factor:   1.359


  10 in total

Review 1.  Radioiodine-131 in the diagnosis and treatment of metastatic well differentiated thyroid cancer.

Authors:  H R Maxon; H S Smith
Journal:  Endocrinol Metab Clin North Am       Date:  1990-09       Impact factor: 4.741

2.  Skull base metastasis from follicular thyroid carcinoma -two case reports-.

Authors:  Akira Matsuno; Hideki Katakami; Ryo Okazaki; So Yamada; Mitsuyoshi Sasaki; Hiroshi Nakaguchi; Shoko M Yamada; Katsumi Hoya; Mineko Murakami; Kazuto Yamazaki; Yasuo Ishida; Hiroyuki Iwasaki; Jyunpei Kuyama; Kennichi Kakudo
Journal:  Neurol Med Chir (Tokyo)       Date:  2010       Impact factor: 1.742

3.  Clinicopathological characteristics and long-term outcome in patients with distant metastases from differentiated thyroid cancer.

Authors:  Carlos A Benbassat; Sara Mechlis-Frish; Dania Hirsch
Journal:  World J Surg       Date:  2006-06       Impact factor: 3.352

4.  Nasal secretion of iodine-131.

Authors:  I Boxen; Z M Zhang
Journal:  Clin Nucl Med       Date:  1990-09       Impact factor: 7.794

5.  Impact of SPECT and integrated low-dose CT after radioiodine therapy on the management of patients with thyroid carcinoma.

Authors:  Juri Ruf; Lukas Lehmkuhl; Helga Bertram; Dirk Sandrock; Holger Amthauer; Beatrice Humplik; Dieter Ludwig Munz; Roland Felix
Journal:  Nucl Med Commun       Date:  2004-12       Impact factor: 1.690

6.  Increased uptake on I-131 whole-body scintigraphy in Warthin tumor despite false-negative Tc-99m pertechnetate salivary gland scintigraphy.

Authors:  Meltem Caglar; Murat Tuncel; Alp Usubutun
Journal:  Clin Nucl Med       Date:  2003-11       Impact factor: 7.794

7.  Determination of iodine-131 diagnostic dose for imaging metastatic thyroid cancer.

Authors:  N B Arnstein; J E Carey; S A Spaulding; J C Sisson
Journal:  J Nucl Med       Date:  1986-11       Impact factor: 10.057

Review 8.  Sodium iodide symporter: its role in nuclear medicine.

Authors:  June-Key Chung
Journal:  J Nucl Med       Date:  2002-09       Impact factor: 10.057

9.  [Distant metastasis of differentiated thyroid cancers. Diagnosis by 131 iodine (I 131) and treatment].

Authors:  A F Leger
Journal:  Ann Endocrinol (Paris)       Date:  1995       Impact factor: 2.478

10.  131I SPECT/CT in the follow-up of differentiated thyroid carcinoma: incremental value versus planar imaging.

Authors:  Angela Spanu; Maria E Solinas; Francesca Chessa; Daniela Sanna; Susanna Nuvoli; Giuseppe Madeddu
Journal:  J Nucl Med       Date:  2009-01-21       Impact factor: 10.057

  10 in total
  1 in total

Review 1.  Skull metastasis from follicular thyroid carcinoma: report of three cases and review of literature.

Authors:  Jun Shen; Sufen Wang; Xintong Zhao; Xuefei Shao; Xiaochun Jiang; Yi Dai; Shanshui Xu; Xianwen Pan
Journal:  Int J Clin Exp Pathol       Date:  2015-11-01
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.